{"id":"https://openalex.org/W2104455255","doi":"https://doi.org/10.1158/1535-7163.mct-06-0115","title":"Development of engineered antibodies specific for the Mullerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer","display_name":"Development of engineered antibodies specific for the Mullerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer","publication_year":2006,"publication_date":"2006-08-01","ids":{"openalex":"https://openalex.org/W2104455255","doi":"https://doi.org/10.1158/1535-7163.mct-06-0115","mag":"2104455255","pmid":"https://pubmed.ncbi.nlm.nih.gov/16928831"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-06-0115","doi":"https://doi.org/10.1158/1535-7163.mct-06-0115","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-06-0115","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084770334","display_name":"Qing\u2010An Yuan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qing-an Yuan","raw_affiliation_strings":["1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania and","Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania and","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA ,","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044830720","display_name":"Heidi H. Simmons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heidi H. Simmons","raw_affiliation_strings":["1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania and","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102720068","display_name":"Matthew K. Robinson","orcid":"https://orcid.org/0000-0003-4525-0065","observed_orcids":["https://orcid.org/0000-0003-4525-0065"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew K. Robinson","raw_affiliation_strings":["1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania and","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001175777","display_name":"Maria Russeva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Russeva","raw_affiliation_strings":["1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania and","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000780125","display_name":"Wayne Anthony Marasco","orcid":"https://orcid.org/0000-0003-3764-4611","observed_orcids":["https://orcid.org/0000-0003-3764-4611"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wayne A. Marasco","raw_affiliation_strings":["2Department of Cancer Immunology and AIDS, Dana-Farber Cancer Center, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Cancer Immunology and AIDS, Dana-Farber Cancer Center, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210134579"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050269562","display_name":"Gregory Paul Adams","orcid":"https://orcid.org/0000-0003-4207-2881","observed_orcids":["https://orcid.org/0000-0003-4207-2881"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory P. Adams","raw_affiliation_strings":["1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania and","institution_ids":["https://openalex.org/I1289437631"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.1496,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.86461242,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"5","issue":"8","first_page":"2096","last_page":"2105"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.008100000210106373,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/engineered-antibodies","display_name":"engineered antibodies","score":0.781000018119812},{"id":"https://openalex.org/keywords/single-chain-variable-fragment","display_name":"scFv","score":0.9369999766349792},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.7120000123977661},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7739999890327454},{"id":"https://openalex.org/keywords/phage-display","display_name":"phage display","score":0.7570000290870667},{"id":"https://openalex.org/keywords/antibody-binding-kinetics","display_name":"antibody binding kinetics","score":0.6079999804496765},{"id":"https://openalex.org/keywords/ovarian-surface-epithelium","display_name":"ovarian surface epithelium","score":0.8529999852180481},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.43799999356269836}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7244733572006226},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6597374677658081},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5703481435775757},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5591541528701782},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.49566924571990967},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46202191710472107},{"id":"https://openalex.org/C186268636","wikidata":"https://www.wikidata.org/wiki/Q896217","display_name":"Phage display","level":3,"score":0.44909557700157166},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.43131282925605774},{"id":"https://openalex.org/C125823703","wikidata":"https://www.wikidata.org/wiki/Q1616930","display_name":"Fragment crystallizable region","level":3,"score":0.42816826701164246},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.31375500559806824},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2708207964897156},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10251829028129578},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0883035659790039}],"mesh":[{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000915","descriptor_name":"Antibody Affinity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007135","descriptor_name":"Immunoglobulin Variable Region","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015202","descriptor_name":"Protein Engineering","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D018000","descriptor_name":"Receptors, Peptide","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018000","descriptor_name":"Receptors, Peptide","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018000","descriptor_name":"Receptors, Peptide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018125","descriptor_name":"Receptors, Transforming Growth Factor beta","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019151","descriptor_name":"Peptide Library","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-06-0115","doi":"https://doi.org/10.1158/1535-7163.mct-06-0115","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-06-0115","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:16928831","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16928831","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5251577548","display_name":"FCCC-PENN SPORE in Ovarian Cancer","funder_award_id":"P50CA083638","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":61,"referenced_works":["https://openalex.org/W6982722","https://openalex.org/W1523945394","https://openalex.org/W1549258100","https://openalex.org/W1570355045","https://openalex.org/W1918283392","https://openalex.org/W1932132006","https://openalex.org/W1972018125","https://openalex.org/W1983366135","https://openalex.org/W1986331148","https://openalex.org/W1989805938","https://openalex.org/W1990438615","https://openalex.org/W1991928575","https://openalex.org/W1994679552","https://openalex.org/W2001363722","https://openalex.org/W2001900604","https://openalex.org/W2008137045","https://openalex.org/W2010317565","https://openalex.org/W2015552576","https://openalex.org/W2018882616","https://openalex.org/W2018952758","https://openalex.org/W2022978619","https://openalex.org/W2027269306","https://openalex.org/W2031271949","https://openalex.org/W2034647529","https://openalex.org/W2034801324","https://openalex.org/W2034887357","https://openalex.org/W2040465505","https://openalex.org/W2042017376","https://openalex.org/W2052024048","https://openalex.org/W2052601288","https://openalex.org/W2054389360","https://openalex.org/W2059972525","https://openalex.org/W2062221351","https://openalex.org/W2066249105","https://openalex.org/W2067336113","https://openalex.org/W2067857310","https://openalex.org/W2072929827","https://openalex.org/W2079365532","https://openalex.org/W2082245020","https://openalex.org/W2086484290","https://openalex.org/W2089373281","https://openalex.org/W2095817945","https://openalex.org/W2096214890","https://openalex.org/W2103031848","https://openalex.org/W2104863315","https://openalex.org/W2112390984","https://openalex.org/W2121306031","https://openalex.org/W2124687545","https://openalex.org/W2132019814","https://openalex.org/W2137956841","https://openalex.org/W2141592427","https://openalex.org/W2142385140","https://openalex.org/W2148194935","https://openalex.org/W2149807648","https://openalex.org/W2159061602","https://openalex.org/W2163514784","https://openalex.org/W2169233831","https://openalex.org/W4213163782","https://openalex.org/W4246015058","https://openalex.org/W4256017905","https://openalex.org/W4296927411"],"related_works":["https://openalex.org/W2073482926","https://openalex.org/W2082596438","https://openalex.org/W1639311959","https://openalex.org/W1973747410","https://openalex.org/W2140119811","https://openalex.org/W2142385140","https://openalex.org/W2992697783","https://openalex.org/W2169233831","https://openalex.org/W2379009878","https://openalex.org/W1918283392"],"abstract_inverted_index":{"The":[0,130],"M\u00fcllerian":[1,11,44],"inhibiting":[2,45,54],"substance":[3,46],"type":[4],"II":[5],"receptor":[6],"(MISIIR)":[7],"is":[8,28,35],"involved":[9],"in":[10,164],"duct":[12],"regression":[13],"as":[14,109,145],"part":[15],"of":[16,19,53,57,95,114,133,151,185,196],"the":[17,20,55,93,112,134,146,149,194],"development":[18],"male":[21],"reproductive":[22],"system.":[23],"In":[24],"adult":[25],"females,":[26],"MISIIR":[27,76,98,187],"present":[29],"on":[30,38,188],"ovarian":[31,41,60,67,161,190],"surface":[32],"epithelium":[33],"and":[34,66,86,106,141,168,198],"frequently":[36],"expressed":[37],"human":[39,59,97,116,124,160,189],"epithelial":[40],"cancer":[42,61,68],"cells.":[43],"has":[47],"been":[48],"found":[49],"to":[50,73,159],"be":[51,78],"capable":[52],"growth":[56,87],"primary":[58],"cells":[62,163,192],"derived":[63],"from":[64,122],"ascites":[65],"cell":[69],"lines.":[70],"This":[71],"suggested":[72],"us":[74],"that":[75,176],"could":[77],"an":[79],"attractive":[80],"target":[81],"for":[82,111,148,193],"antibody-based":[83,154,177],"tumor":[84],"targeting":[85,186],"inhibition":[88],"strategies.":[89],"Here,":[90],"we":[91],"describe":[92],"production":[94],"recombinant":[96],"extracellular":[99],"domain-human":[100],"immunoglobulin":[101],"Fc":[102],"domain":[103],"fusion":[104],"proteins":[105],"their":[107],"use":[108],"targets":[110],"selection":[113],"MISIIR-specific":[115],"single-chain":[117],"variable":[118],"fragments":[119],"(scFv)":[120],"molecules":[121],"a":[123,181],"nonimmune":[125],"scFv":[126,137],"phage":[127],"display":[128],"library.":[129],"binding":[131],"kinetics":[132],"resulting":[135],"anti-MISIIR":[136],"clones":[138],"were":[139,143],"characterized":[140],"two":[142],"employed":[144],"basis":[147],"construction":[150],"bivalent":[152],"scFv:Fc":[153],"molecules.":[155],"Both":[156],"bound":[157],"specifically":[158],"carcinoma":[162,191],"flow":[165],"cytometry":[166],"assays":[167],"cross-reacted":[169],"with":[170],"mouse":[171],"MISIIR.":[172],"These":[173],"results":[174],"indicate":[175],"constructs":[178],"may":[179],"provide":[180],"highly":[182],"specific":[183],"means":[184],"purpose":[195],"diagnosing":[197],"treating":[199],"this":[200],"disease.":[201]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}